VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Rob McWhirter

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Apr 12, 2021 2:09pm

335 Views

Post# 32978508

RE:RE:Rob McWhirter

Agreed Pandora, but it appears some accumulation going on in market today...maybe some new eyes on VPT due to McWhirter comments?

Pandora wrote:

Pandora wrote:
A very good pump by Rob McWhirter on BNN MarketCall a few minutes ago. He was very high on the China component mentioning a possibilty of the Chinese FDA requiring the technology in 'all' hospitals.

Looking at the action re price and volume I can't believe how quiet the board is. Almost like they give no credence to McWhirter and his comments but they're not even making that comment. A little different -- that's all.